Buy Novus Therapeutics Stock | TKAI Stock Price & Latest News | Public
TKAI

Novus Therapeutics

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About TKAI

    Novus Therapeutics Inc. engages in the research and development of pharmaceutical products for patients with disorders of the ear, nose, and throat. The company operates under the surfactant and foam platforms. The surfactant platform develops a treatment option for oti...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -2.84
    -5.68
    -8.52
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$2.79

    Actual EPS
    Q4 2020

    Stats

    Market Cap$26,3M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$27.32
    1 Year Low$4.50
    Open$25.07
    High$25.15
    Low$24.31

    Buy any stock with any amount of money.

    Download the App
    Download the app